on 28 May 2019
Last Applicant/ Owned by
CHIVERS WAY, HISTON
CAMBRIDGE
GB
CB249BZ
Serial Number
87771739 filed on 26th Jan 2018
Registration Number
5765928 registered on 28th May 2019
Correspondent Address
Michael T. Olsen
Filing Basis
1. intent to use
Disclaimer
"RESEARCH INSTITUTE"
Providing online non-downloadable electronic publications in the nature of newsletters, journals, and books in the field of cannabinoid-based medicines; arranging, conducting and organisation of educational conferences, congresses, seminars and symposiums in the field of cannabinoid-based medicines; information, advisory and consultancy services in relation to all of the aforesaid services "RESEARead More
Providing online non-downloadable electronic publications in the nature of newsletters, journals, and books in the field of cannabinoid-based medicines; arranging, conducting and organisation of educational conferences, congresses, seminars and symposiums in the field of cannabinoid-based medicines; information, advisory and consultancy services in relation to all of the aforesaid services
Scientific and technological services and research and design relating thereto, namely, scientific research in the field of cannabinoid-based medicines, research on the subject of pharmaceuticals, and pharmaceutical drug development services, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical research and development services all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research, testing and development of pharmaceutical and veterinary preparations all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; biological, clinical and medical research all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; conducting clinical trials for others all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; information, advisory and consultancy services in relation to all of the aforesaid services
No 87771739
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
15th Sep 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
15th Sep 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
15th Sep 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
15th Sep 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
28th Jul 2021 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
28th May 2019 | REGISTERED-SUPPLEMENTAL REGISTER |
24th Apr 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
17th Apr 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
12th Apr 2019 | ASSIGNED TO LIE |
25th Mar 2019 | EXAMINERS AMENDMENT -WRITTEN |